Severe Aortic Stenosis Clinical Trial
Official title:
Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery
Acquired Von Willebrand disease (type 2A) has been described in patients with severe aortic
stenosis, the association of aortic stenosis and Digestive bleeding due to this phenomena
has received the name of Heye´s syndrome.
We propose that administering Desmopressin (DDAVP) in patients scheduled to aortic valve
replacement surgery will reduce blood loss and transfusion rate.
this was a pilot study
Randomized Controlled trial compared with placebo in a double blind fashion. Subjects with
severe aortic stenosis (transvalvular gradient >50 mmHg or valvular area of lass than 1 cm2)
scheduled for aortic valve replacement were enrolled.
the day of surgery blood samples were taken in order to confirm diagnosis (factor VIII
activity and Protein electrophoresis for Von Willebrand´s multimers) and then 0,3 mcg/k of
DDAVP or saline equally labeled as "study drug" were administered en 30 minutes a half hour
before incision.
Blood loss, postoperative hematocrit and transfusion requirement were measured, plasma
sodium was measured as a safety issue.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01238497 -
SOURCE XT REGISTRY
|
||
Recruiting |
NCT04029844 -
Colibri Transcatheter Aortic Heart Valve System Study
|
N/A | |
Recruiting |
NCT03280433 -
Influence of EPICardial Adipose Tissue in HEART Diseases: EPICHEART Study
|
N/A | |
Completed |
NCT05492383 -
SAvvyWireâ„¢ EFficacy and SafEty in Transcatheter Aortic Valve Implantation Procedures (SAFE-TAVI)
|
N/A | |
Active, not recruiting |
NCT03752866 -
The CONFIDENCE Registry
|
N/A | |
Completed |
NCT01651780 -
Open-label, Randomized Trial in Patients Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH
|
Phase 3 | |
Recruiting |
NCT06173115 -
Comparison of a Single Versus Double Perclose Technique for TAVR
|
N/A | |
Recruiting |
NCT06136429 -
A Prospective, Multicenter, Single-arm Study to Evaluate a Transcatheter Aortic Valve System Safety and Efficacy for the Treatment of Patients With Severe Aortic Stenosis
|
N/A | |
Not yet recruiting |
NCT06015997 -
Prevalence of ATTR Cardiac Amyloidosis in Patients Undergoing TAVR
|
||
Recruiting |
NCT03291925 -
Primary Non-invasive Cardiac Computed Tomography Versus Routine Invasive Angiography Prior to TAVI
|
N/A | |
Terminated |
NCT03004599 -
Safety and Efficacy of SYM-SV/DS-002 in Patients With Severe Aortic Stenosis
|
N/A | |
Recruiting |
NCT04076150 -
Safety and Performance Study of the Optimum Transcatheter Aortic Valve
|
N/A | |
Completed |
NCT01074658 -
CoreValve Advance International Post Market Study
|
N/A | |
Completed |
NCT02575768 -
Myocardial Flow Reserve in Severe AS Without Obstructive Coronary Artery Disease
|
N/A | |
Completed |
NCT04286893 -
Improved HRV, Inflammation Markers and Endothelial Function After TAVI
|
||
Not yet recruiting |
NCT06177392 -
VARC-TAVI VALVE IMPLANTATION)
|
N/A | |
Active, not recruiting |
NCT04206228 -
Intravenous Iron Supplement for Iron Deficiency in Patients With Severe Aortic Stenosis
|
Phase 2 | |
Not yet recruiting |
NCT03788590 -
Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System
|
N/A | |
Completed |
NCT01531374 -
Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement
|
N/A | |
Recruiting |
NCT05493657 -
Aspirin vs Clopidogrel After TAVR
|
N/A |